AnPac Bio 2023 First Half Revenue Up 128.5% with Non-GAAP Loss Reduced by 18.3%
PHILADELPHIA, Oct. 01, 2023 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its unaudited financial results for the six…